weight loss drug market is just beginning to take off, says mizuho's jared holz
Published 1 year ago • 2.1K plays • Length 4:08Download video MP4
Download video MP3
Similar videos
-
5:05
amgen has 'a lot to prove' in the weight-loss drug category, says mizuho's jared holz
-
7:35
eli lilly's zepbound single-dose vials will expand access to more patients: mizuho's jared holz
-
5:47
drugs for obesity are a massive market, says mizuho's jared holz
-
5:05
pfizer is far behind weight loss drug race despite pill trial, says mizuho's jared holz
-
5:53
eli lilly and novo nordisk will remain leaders in the weight-loss drug market: mizuho's jared holz
-
4:25
people are 'scratching and clawing' for negative narrative around obesity drugs: mizuho's jared holz
-
5:12
structure therapeutics is a 'no-brainer takeout' target, says mizuho's jared holz
-
5:52
expectations for pfizer have been low, says mizuho's jared holz on weight-loss pill setback
-
3:53
eli lilly's alzheimer drug is 'a nice additional therapy', says mizuho's jared holz
-
6:00
eli lilly's zepbound may be best-in-breed for weight loss drugs, says dr. kavita patel
-
6:08
eli lilly's dtc obesity drug push 'not necessarily an industry game changer': mizuho's jared holz
-
5:52
pharma industry remains in 'early innings' of new weight loss drug boom, says scott gottlieb
-
6:00
mizuho's jared holz reacts to jpmorgan's huge obesity drug call
-
3:43
mizuho's holz on weight loss drugs: lilly and novo nordisk are in excellent shape fundamentally
-
5:47
zealand's obesity drug shouldn't disrupt novo nordisk-eli lilly leadership: mizuho's jared holz
-
1:55
cramer: the market sell-off is a seasonal self-fulfilling prophecy
-
10:52
wegovy, ozempic or mounjaro? how a new wave of weight loss drugs could transform the diet industry
-
6:01
what other industries could weight loss drugs disrupt?
-
4:57
health care bucks sell-off as eli lilly soars: mizuho's jared holz on what's next for the group